Bacillus subtilis Molecular Biology Testing

Bacillus subtilis Molecular Biology Testing – Genotypic Authentication, Functional Gene Profiling & Strain Characterisation

You are searching for Bacillus subtilis molecular biology testing because you need to perform this assay—whether to confirm species identity, detect specific functional genes (e.g., protease, amylase, lipase, antibiotic synthesis), monitor plasmid retention or gene expression in engineered strains, or evaluate genetic stability during fermentation. We provide a complete molecular testing service that delivers high‑resolution genotyping, absolute gene quantification, transcriptional analysis, and whole‑genome fingerprinting for B. subtilis in research, quality control, or industrial process monitoring.

What We Detect – Species‑Specific Markers, Functional Genes, Plasmids & Mutations

Our B. subtilis molecular testing goes far from simple 16S rRNA PCR. Using real‑time PCR (qPCR) with species‑specific primers targeting gyrB, rpoB, and spo0A, we achieve unambiguous identification down to 10 genome copies/reaction, discriminating B. subtilis from closely related B. licheniformis, B. amyloliquefaciens, and B. pumilus. For functional characterisation, we deploy multiplex qPCR panels (up to 10 targets/well) to detect and quantify genes for protease (aprE, nprE), α‑amylase (amyE), lipase (lipA), surfactin synthesis (srfAA, sfp), poly‑γ‑glutamate (pgsA), and lantibiotic production (spaS, spaC) – with sensitivity of 1 fg of purified DNA and linear range over 6 logs. For engineered strains, we measure plasmid copy number (PCN) by qPCR or digital droplet PCR (ddPCR) targeting the plasmid origin of replication and a single‑copy chromosomal reference – achieving absolute copy number per genome with ±5% precision. We also perform gene expression analysis (RT‑qPCR) for up to 20 target genes under your specific culture conditions (e.g., sporulation, stationary phase, inducer addition), reporting fold change relative to reference genes (rpoA, 16S rRNA). For mutation detection (e.g., to verify gene knockouts or point mutations), we use Sanger sequencing (bidirectional, 800‑1000 bp reads) or targeted amplicon deep sequencing (Illumina, >10,000× coverage) to detect rare mutations down to 1% frequency in a mixed population.

How Deep We Go – Whole‑Genome Sequencing, CRISPR Engineering Validation & Strain Typing

We don't just report “positive” or “negative”. Our advanced pipeline includes whole‑genome sequencing (WGS) of B. subtilis isolates or engineered strains (Illumina NovaSeq, 300× coverage, complete genome assembly with long‑read Nanopore bridging when required) to deliver complete chromosome and plasmid sequences, annotation of all functional genes, and detection of unplanned mutations (SNPs, indels, structural variants). For CRISPR‑edited strains, we provide on‑target and off‑target analysis by WGS and computational prediction (CRISTA, CRISPOR), confirming that only the intended edit is present. For strain typing and provenance tracking, we perform MLST (multilocus sequence typing) on 7 housekeeping genes and repetitive‑element PCR (rep‑PCR) using BOX, ERIC, and REP primers – generating unique fingerprint profiles for batch‑to‑batch comparison. To assess genetic stability, we run mutation accumulation assays (serial passaging for 50‑200 generations) followed by whole‑genome resequencing, calculating mutation rate (per genome per generation) – critical for industrial production strains. For comparative genomics among multiple B. subtilis isolates, we deliver core‑genome SNP trees, accessory genome heatmaps, and pan‑genome analysis with full annotation of CAZymes, secondary metabolite clusters, and stress response genes.

Why Our B. subtilis Molecular Testing Stands Out – High Specificity, Absolute Quantitation & GMP‑Compatible Reporting

1. Unambiguous species discrimination: Our qPCR assays are validated against 50+ Bacillus strains and show zero cross‑reactivity with common contaminants (E. coli, Pseudomonas, Lactobacillus). For ambiguous cases, we confirm by MALDI‑TOF mass spectrometry and gyrB sequencing.
2. Absolute gene copy numbers without standard curves: Using droplet digital PCR (ddPCR) with dual‑labelled probes, we quantify target DNA copies in copies/μL or copies/ng of genomic DNA – no need for serial dilutions or standard curves, and unaffected by PCR inhibitors. This is ideal for plasmid copy number and residual DNA in fermentation products.
3. High‑throughput & rapid turnaround: For strain identity and functional gene screening, we process up to 384 samples per run and deliver results in 24‑48 hours. For WGS (complete genome), we deliver draft assembly within 5 business days, polished closed genome within 10 days.
4. Integrated support for regulatory & industrial needs: Our reports meet GMP/GLP requirements for microbial seed lot characterisation, genetic stability studies for biologic license applications, and ISO 17025 for molecular methods. We also provide detailed protocols and validation data for assay transfer to your QC lab.
5. Expert interpretation: Beyond raw data, we highlight functional gene presence/absence, potential plasmid loss risk (based on PCN), unintended mutations that might affect sporulation or enzyme yield, and strain relatedness to reference strains – actionable insights for process optimisation.

Who Relies on Our B. subtilis Molecular Testing – Real‑World Impact

A probiotic manufacturer used our multiplex qPCR panel to screen 20 B. subtilis isolates for surfactin and lantibiotic genes – we identified a strain with both srfAA and spaS, which showed superior antimicrobial activity. An enzyme production company sent us engineered B. subtilis strains expressing high‑level protease; our plasmid copy number analysis (ddPCR) revealed that only strains with >40 copies of the expression plasmid achieved target titres, guiding their transformation optimisation. A university research group studying sporulation defects used our whole‑genome sequencing and comparison to pinpoint a single nucleotide deletion in spoIIID – missed by PCR screening. A contract manufacturing organisation needed to verify that their production strain had not genetically drifted after 100 generations; our mutation accumulation + WGS showed zero unplanned mutations, confirming genetic stability for regulatory filing.

Ready to Run Your B. subtilis Molecular Testing?

Send us pure bacterial culture (slants, plates, or liquid overnight culture), extracted DNA (≥100 ng), or fermentation samples (≥1 mL). We will perform species identification by qPCR/sequencing, functional gene profiling, plasmid copy number quantification, gene expression analysis (RT‑qPCR), or full whole‑genome sequencing – delivering a comprehensive report with actionable molecular insights within 1‑10 business days based on complexity. Request a free consultation; we will design the optimal molecular testing panel (identity only, functional screening, plasmid stability, or full genome characterisation) for your B. subtilis strain development, QC release, or regulatory submission.